"Interleukin-8" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells.
| Descriptor ID |
D016209
|
| MeSH Number(s) |
D12.644.276.374.200.120.800 D12.644.276.374.465.312 D12.776.467.374.200.120.800 D12.776.467.374.465.246 D23.125.300.120.800 D23.469.200.120.800 D23.529.374.200.120.800 D23.529.374.465.312
|
| Concept/Terms |
Interleukin-8- Interleukin-8
- Interleukin 8
- IL8
- Monocyte-Derived Neutrophil Chemotactic Factor
- Neutrophil Activation Factor
- Neutrophil-Activating Peptide, Lymphocyte-Derived
- Lymphocyte-Derived Neutrophil-Activating Peptide
- Neutrophil Activating Peptide, Lymphocyte Derived
- Neutrophil-Activating Peptide, Monocyte-Derived
- Monocyte-Derived Neutrophil-Activating Peptide
- Neutrophil Activating Peptide, Monocyte Derived
- Alveolar Macrophage Chemotactic Factor-I
- Alveolar Macrophage Chemotactic Factor I
- AMCF-I
- Anionic Neutrophil-Activating Peptide
- Anionic Neutrophil Activating Peptide
- Neutrophil-Activating Peptide, Anionic
- Peptide, Anionic Neutrophil-Activating
- Chemokine CXCL8
- CXCL8, Chemokine
- Chemokines, CXCL8
- CXCL8 Chemokines
- Chemotactic Factor, Macrophage-Derived
- Chemotactic Factor, Macrophage Derived
- Macrophage-Derived Chemotactic Factor
- Chemotactic Factor, Neutrophil
- Neutrophil Chemotactic Factor
- Chemotactic Factor, Neutrophil, Monocyte-Derived
- CXCL8 Chemokine
- Chemokine, CXCL8
- Granulocyte Chemotactic Peptide-Interleukin-8
- Chemotactic Peptide-Interleukin-8, Granulocyte
- Granulocyte Chemotactic Peptide Interleukin 8
- IL-8
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-8".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-8".
This graph shows the total number of publications written about "Interleukin-8" by people in this website by year, and whether "Interleukin-8" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 3 | 1 | 4 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 2 | 2 |
| 1998 | 1 | 1 | 2 |
| 1999 | 1 | 3 | 4 |
| 2000 | 1 | 2 | 3 |
| 2001 | 1 | 2 | 3 |
| 2002 | 3 | 3 | 6 |
| 2003 | 3 | 4 | 7 |
| 2004 | 4 | 3 | 7 |
| 2005 | 3 | 6 | 9 |
| 2006 | 2 | 6 | 8 |
| 2007 | 2 | 1 | 3 |
| 2008 | 4 | 4 | 8 |
| 2009 | 2 | 1 | 3 |
| 2010 | 2 | 4 | 6 |
| 2011 | 1 | 6 | 7 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 1 | 3 |
| 2014 | 4 | 5 | 9 |
| 2015 | 4 | 2 | 6 |
| 2016 | 2 | 5 | 7 |
| 2017 | 2 | 4 | 6 |
| 2018 | 0 | 1 | 1 |
| 2019 | 3 | 2 | 5 |
| 2020 | 0 | 5 | 5 |
| 2021 | 0 | 1 | 1 |
| 2022 | 0 | 3 | 3 |
| 2023 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-8" by people in Profiles.
-
Unlocking the Pancreatic Cancer Puzzle: Using Intermediate Cells to Target Treatment. Clin Cancer Res. 2024 Jun 03; 30(11):2297-2299.
-
Microvascular activation and exocytosis after exposure to the serum from mismatched recipients by using donor microvascular cultures. Transpl Immunol. 2024 02; 82:101963.
-
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study. Lancet Microbe. 2023 09; 4(9):e692-e703.
-
Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging. BMC Med. 2023 04 05; 21(1):133.
-
Very Low Driving-Pressure Ventilation in Patients With COVID-19 Acute Respiratory Distress Syndrome on Extracorporeal Membrane Oxygenation: A Physiologic Study. J Cardiothorac Vasc Anesth. 2023 03; 37(3):423-431.
-
Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease. Hepatology. 2023 02 01; 77(2):530-545.
-
Plasma protein biomarkers for primary graft dysfunction after lung transplantation: a single-center cohort analysis. Sci Rep. 2022 09 27; 12(1):16137.
-
Integrated PERSEVERE and endothelial biomarker risk model predicts death and persistent MODS in pediatric septic shock: a secondary analysis of a prospective?observational?study. Crit Care. 2022 07 11; 26(1):210.
-
Cohort study on the differential expression of inflammatory and angiogenic factors in thrombi, cerebral and peripheral plasma following acute large vessel occlusion stroke. J Cereb Blood Flow Metab. 2022 10; 42(10):1827-1839.
-
Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression. Breast Cancer Res Treat. 2021 Sep; 189(2):333-345.